With mRNA vaccine, India will have flexibility against COVID-19: Scientist, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country’s first potential mRNA vaccine candidate to fight against SARS-CoV-2, stating that it has an advantage of flexibility which isn’t with other vaccine platforms., The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country’s first potential mRNA vaccine candidate to fight against SARS-CoV-2, stating that it has an advantage of flexibility which isn’t with other vaccine platforms., , Read More